Results 31 to 40 of about 137,942 (365)

Barriers and facilitators related to healthcare practitioner use of real time prescription monitoring tools in Australia

Frontiers in Public Health, 2023
IntroductionReal time prescription monitoring tools have been implemented in Australia to address the growing concerns of drug misuse, drug-related mortality and morbidity. The objective of this pilot study is to investigate the barriers and facilitators
Dimi Hoppe, Chaojie Liu, Hanan Khalil
doaj   +1 more source

Health-care practitioner use of prescription drug monitoring programs in clinical practice in Australia: A qualitative study.

Drug and Alcohol Review, 2023
INTRODUCTION Prescription drug monitoring programs (PDMP) are electronic databases used by prescribers and pharmacists to monitor the use of high-risk prescription medications subject to extramedical use.
Dimi Hoppe, Chaojie George Liu, H. Khalil   +2 more
semanticscholar   +1 more source

Systematic Literature Review of Prescription Drug Monitoring Programs. [PDF]

AMIA Annu Symp Proc, 2018
Ponnapalli A, Grando A, Murcko A, Wertheim P.   +3 more
europepmc   +2 more sources

How clinicians use prescription drug monitoring programs: a qualitative inquiry. [PDF]

Pain Med, 2014
Hildebran C, Cohen DJ, Irvine JM, Foley C, O'Kane N, Beran T, Deyo RA.   +6 more
europepmc   +3 more sources

Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians. [PDF]

Health Aff (Millwood), 2016
Bao Y, Pan Y, Taylor A, Radakrishnan S, Luo F, Pincus HA, Schackman BR.   +6 more
europepmc   +2 more sources

Prescribed stimulant medications: Trends in the last decade, pre and post COVID-19 response

Exploratory Research in Clinical and Social Pharmacy, 2023
Background: Recent studies indicate that COVID-19 has had a significant impact on access and continuity to opioid and benzodiazepine medications; little is known about its effect on access to and utilization of stimulant medications.
Meelee L. Kim, Netrali Dalvi, Danielle DeNufrio Valerio, Gail K. Strickler, Leonard D. Young   +4 more
doaj   +1 more source

Measuring Relationships Between Proactive Reporting State-level Prescription Drug Monitoring Programs and County-level Fatal Prescription Opioid Overdoses. [PDF]

Epidemiology, 2020
BACKGROUND Prescription drug monitoring programs (PDMPs) that collect and distribute information on dispensed controlled substances have been adopted by nearly all US states.
Cerdá M, Ponicki WR, Smith N, Rivera-Aguirre A, Davis CS, Marshall BDL, Fink DS, Henry SG, Castillo-Carniglia A, Wintemute GJ, Gaidus A, Gruenewald PJ, Martins SS.   +12 more
europepmc   +2 more sources

Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses: A Systematic Review. [PDF]

Ann Intern Med, 2018
The overuse of prescription opioids during the past 2 decades has evolved into a major public health issue in the United States. Opioid prescribing increased 350% between 1999 and 2015, from 180 to 640 morphine milligram equivalents per capita (1), with ...
Fink DS, Schleimer JP, Sarvet A, Grover KK, Delcher C, Castillo-Carniglia A, Kim JH, Rivera-Aguirre AE, Henry SG, Martins SS, Cerdá M.   +10 more
europepmc   +2 more sources

Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse [PDF]

Journal of Policy Analysis and Management, 2018
AbstractDespite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug monitoring (PDMP) programs, which constitute a key policy targeting access to non‐medical ...
Anca M, Grecu, Dhaval M, Dave, Henry, Saffer   +2 more
openaire   +2 more sources

Consumo de antibióticos en atención primaria en población adulta de Asturias durante el periodo 2014-2020

Atención Primaria, 2022
Resumen: Objetivo: Estudiar la evolución del consumo de antibióticos en población adulta en el ámbito de Atención Primaria (AP) del Servicio de Salud del Principado de Asturias (SESPA) durante 2014-2020.
María Luisa Nicieza García, Pablo Pérez Solís, Constanza Gómez de Oña, Patricio Suárez Gil, Valeria Rolle Sóñora, Belén Suárez Mier   +5 more
doaj   +1 more source